(NASDAQ: RPID) Rapid Micro Biosystems's forecast annual revenue growth rate of 19.24% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 6.21%, and it is also forecast to beat the US market's average forecast revenue growth rate of 12.3%.
Rapid Micro Biosystems's revenue in 2026 is $35,176,000.On average, 7 Wall Street analysts forecast RPID's revenue for 2026 to be $2,009,692,771, with the lowest RPID revenue forecast at $1,892,520,048, and the highest RPID revenue forecast at $2,143,568,626. On average, 7 Wall Street analysts forecast RPID's revenue for 2027 to be $2,369,838,383, with the lowest RPID revenue forecast at $2,162,880,055, and the highest RPID revenue forecast at $2,580,709,156.
In 2028, RPID is forecast to generate $3,082,555,514 in revenue, with the lowest revenue forecast at $2,728,178,251 and the highest revenue forecast at $3,423,389,697.